Objective: The cognitive benefit of postmenopausal hormone use is controversial; however, timing of treatment close to menopause may increase the likelihood of preserving cognitive function. We examined the effects of earlyinitiation hormone use on visual working memory, hypothesizing that long-term hormone use is associated with greater brain activation during visual working memory.
strogens are present throughout the central nervous system, contributing to neuronal integrity and cognitive function. 1<4 As women approach menopause, declining estrogen levels may negatively affect learning and memory. 5, 6 Early observations suggested that estrogen treatment preserves cognitive ability; however, clinical trials have not uniformly supported this conclusion. 7<11 Increasing evidence suggests that beginning treatment within a Bcritical window[ is necessary to achieve a cognitive benefit. 8,11<16 Contrary to previous observational studies, the Women's Health Initiative Memory Study (WHIMS) found an increased risk of dementia and mild cognitive impairment in women, all older than 65 years, randomized to estrogen or combined estrogen and progestin therapies. 17<22 Paradoxically, a substudy of WHIMS, the Women's Health Initiative Study of Cognitive Aging, found a trend toward a benefit of hormone use in nonverbal cognitive domains. 23 These studies demonstrate the limitations of hormone use initiated well past menopause, but it is unclear whether the conclusions can be extrapolated to earlier hormone initiation.
Reviews of randomized studies conclude that earlier treatment yields cognitive benefits in most studies, whereas later hormone use is not associated with such benefit. 8, 9 Similarly, a follow-up study of early postmenopausal women randomized to hormones or placebo detected less cognitive impairment in those who received active hormones. 24 Likewise, in the Research into Memory, Brain Function, and Estrogen Replacement (REMEMBER) study, early hormone initiators performed better than late initiators on tests of attention, concentration, and mental status. 25 Functional magnetic resonance imaging (fMRI), which indirectly measures synaptic activity in the brain, can provide additional insight into the effects of postmenopausal hormone use on memory and cognition. Our group recently used fMRI to compare brain activity in women after 4 weeks each of placebo and combined estrogen and progestin treatment while they performed a visual memory task. 26 Regional brain activity differed between treatment arms, suggesting that the hormones influenced how visual information was processed.
The present study is a cross-sectional fMRI-based evaluation of visual working memory in early-initiation, long-term estrogen users, combined estrogen and progestin users, and never users of hormones. We compared hormone-treated with never-treated women and evaluated the effects of estrogen therapy (ET) versus combined estrogen and progestin therapy (EPT). We hypothesize that ET and EPT are both associated with increased activity in the frontal cortex, parietal cortex, hippocampus, and parahippocampal gyrus, brain regions known to be involved in visual cognition and working memory.
METHODS

Participants
Three groups of healthy right-handed postmenopausal women, 60 years or older, were recruited by advertisement or through the University of Michigan Women's Health Registry 27, 28 ; women either had taken hormones without interruption for at least 10 years (two groups: ET and EPT) or had never received treatment. All hormone-treated participants began use within 2 years of menopause onset (defined as the absence of menstrual periods for 1 y, onset of severe symptoms after hysterectomy, or the time of hysterectomy with bilateral oophorectomy). Users took the same dose and preparation of estrogen, conjugated equine estrogens 0.625 mg/day (Premarin, Wyeth Pharmaceuticals, Philadelphia, PA), with or without cyclic or continuous medroxyprogesterone acetate (Provera, Pfizer, New York, NY, or Prempro, Wyeth Pharmaceuticals). Fifty-five women were included in the study: 17 ET users, 20 EPT users, and 18 never users.
Hormone therapy (HT) groups included current and past long-term users. Of the treated women, 13 of 37 were currently taking hormones (7/17 women in the ET group and 6/20 women in the EPT group). For those no longer taking hormones, mean (SD) time since treatment was ended was 2.1 (1) years. All women in the ET group had undergone hysterectomy, including 10 (64.7%) of 17 women with bilateral oophorectomy.
Initial telephone screening was followed by medical, psychiatric, and neurologic histories and physical examination. Screening laboratory tests included electrolytes, glucose, complete blood count, thyrotropin, and estradiol. Exclusion criteria included having diabetes, heart disease, cancer, stroke, or other acute or uncorrected medical illnesses; using centrally acting medications, intermittent estrogen, or phytoestrogen supplements; smoking within the last 5 years; being unable to tolerate the scanning procedures; and having contraindications to MRI. After a full description of the study, written informed consent was obtained. All procedures were approved by the University of Michigan's institutional review board.
Study protocol
This was a cross-sectional study of postmenopausal longterm hormone users versus never users. A neuropsychological battery of tests was given to exclude the presence of dementia or specific deficits in visual spatial skills, including the (1) Mini-mental State Examination, 29 a brief screening measure of dementia; (2) Shipley Institute of Living Scale, 30 a short estimate of intellectual power; (3) Geriatric Depression Rating Scale, 31 to exclude the presence of depression; and (4) Benton Visual Retention Test, revised, 32,33 a measure of visual memory ability.
fMRI visual delayed matching-to-sample task
The fMRI paradigm to evaluate visual working memory used a validated visual delayed matching-to-sample task. 34, 35 The visual stimuli consisted of 9 Â 9 grids, with 40 squares darkened to form a random pattern, presented under three conditions: (1) matching to sample, (2) 1-second delayed matching to sample, or (3) 4-second delayed matching to sample. In the matching condition, a target stimulus was presented with two additional test items simultaneously underneath the target. The women selected, via a response pad, which of the test items matched the target. Stimuli were presented for 3 seconds, followed by a 7-second fixation cross before presentation of the next item. The delay conditions assessed visual working memory: the target stimulus was presented alone for 1.5 seconds and was followed by a 1or 4-second delay. After the delay, test items were presented for 3 seconds, during which time women indicated the match. The 4-second delay condition engaged working memory to a greater extent because it required the visual information to be remembered during the delay. Four blocked trials from each condition were counterbalanced over three 6-minute runs, for 180 total scans with a 2-second interscan interval. E-Prime software (Psychology Software Tools Inc., Pittsburgh, PA) was used to control the stimulus presentation timing. To minimize performance differences, participants practiced the task until they achieved at least 70% accuracy.
fMRI acquisition and processing
Scans were acquired using a 3-T whole-body MRI scanner (General Electric, Milwaukee, WI) equipped with a standard head coil. Anatomical MRI scans were acquired axially with a spoiled gradient recalled three-dimensional volumetric acquisition (repetition time, 9.6 ms; echo time, 3.3 ms; inversion recovery preparation, 200 ms; flip angle, 17-; bandwidth, 15.63 hertz; 24-cm field of view; 1.5-mm slice thickness; 106-110 slices; 256 Â 256 matrix; two excitations). fMRI acquisition was sensitized for the blood oxygen levelY dependent (BOLD) effect using a T2*-weighted single-shot spiral pulse sequence with 32 oblique-axial slices prescribed to be approximately parallel to the anterior commissur-eYposterior commissure line (spiral gradient echo: echo time, 25 ms; repetition time, 2,000 ms; flip angle, 60-; 4mm-thick contiguous slices; 24-cm field of view; 64 Â 64 image matrix). Image reconstruction included processing steps to remove distortions caused by magnetic field inhomogeneity and other sources of misalignment to the structural data. 36 Data were sync-interpolated in time, slice by slice, to correct for the staggered sequence of slice acquisition. 37 The first four functional volumes of each run were discarded to remove magnetic saturation effects, and the remaining images were realigned to the fifth volume to eliminate movement artifacts using SPM2-based algorithms. 38 Realignment parameters for each participant were examined to ensure that head movement did not exceed 2 mm. Anatomical and functional images were coregistered to each other through rigid body affine transformation using a mutual information algorithm, as previously described. 39 The participant's MRI was spatially normalized into standard stereotactic space via linear and nonlinear warping, to a minimum deformation template derived from T1-weighted magnetic resonance images from 25 normal older women, created by the Imaging of Dementia and Aging Laboratory at the University of California, Davis. 40 The transformation matrix was applied to all functional images, and a threedimensional Gaussian smoothing kernel set at 8 mm full-width at half-maximum was applied to accommodate for residual anatomical variability and improve signal-to-noise ratios.
fMRI data analysis fMRI data analyses were conducted using the general linear model in SPM2 (Wellcome Department of Cognitive Neurology, London, UK). For the first-level analyses, contrast images were generated for each participant to assess activation differences between visual task conditions. These initial contrast images (4-s and 1-s delay matching) were subtracted from each other to isolate the visual working memory component. We assessed the effects of hormone use using this working memory component. Regions included in our analysis were significant at false discovery rateYcorrected P G 0.05 using a one-sample t test to evaluate the effect of task in our study population, as well as regions deemed significant by a priori hypothesis at uncorrected P G 0.001. Regions meeting this criterion were included in further evaluations. An initial effect-of-treatment analysis was performed using analysis of variance with treatment group as the independent variable and 4-second delay j 1-second delay fMRI-BOLD signal as the dependent variable. Subsequent post hoc analyses were performed between treatment groups using two-sample t tests and general linear models. A correlation between task performance and brain activation during the visual task was determined using multiple linear regression in SPM2 and confirmed with partial correlation analyses (to describe the linear relationship between performance and activation while holding age and education constant) in SPSS (SPSS Inc., Chicago, IL), using A coefficients extracted from the regions found to be correlated in SPM2. All comparisons between the two HT groups were made controlling for age and education level, and comparisons between the hormoneusing groups or between past and current hormone users were made additionally controlling for duration of treatment and age at treatment initiation.
RESULTS
Study demographics
The demographic and baseline information for the study participants is given in Table 1 . Neuropsychological testing documents normal IQ, spatial perception and memory, and absence of dementia and depression. The mean (SD) age of the participants was 66.2 (5.5) years. In the three-group comparison, there were no demographic differences between the groups. Post hoc two-group comparisons show that age, education, age at treatment initiation, and duration of hormone use differ between the ET and EPT groups. Current and past hormone users were similar to each other in most respects, except that current hormone users had fewer years of education than past users did.
Neuroimaging task performance
There were no significant differences between treatment groups on the visual memory task. Women in the ET group scored 82% T 11% and 80% T 10% correct, those in the EPT group scored 85% T 10% and 82% T 11% correct, and those in the never-treated group scored 88% T 9% and 86% T 8% correct for the 1-and 4-second delay tasks, respectively (twotailed unpaired t tests, P 9 0.05). Current and past hormone users did not score significantly differently from each other on the visual memory task: current users had a mean accuracy of 78.6% T 9.9% and past users had a mean accuracy of 82.8% T 11.1%.
Regional activity during visual working memory task
For all participants, regions activated by the visual working memory task are detailed in Table 2 , including the right inferior frontal cortex, anterior cingulate, bilateral anterior insula, bilateral superior parietal cortex, left hippocampus and bilateral parahippocampal gyrus, and the midbrain raphe region. After introducing age and education as covariates, activation patterns remained similar, except that the right parahippocampal gyrus and the raphe no longer achieved statistical significance. Further activations became significant in the left prefrontal cortex (z = 3.11), anterior cingulate (z = 3.96), right hippocampus (z = 2.96), and posterior cingulate (z = 3.95).
Task performance correlations to regional activation
We used linear regression and partial correlation analyses to assess correlations between regional activation and performance on the 1-and 4-second delay conditions of the visual task, controlling for age and education, across the entire sample. Performance accuracy for the 1-second delay condition was not positively or negatively correlated to increased activation anywhere in the brain. For the 4-second delay condition, increased activation was positively correlated with better performance in the right hippocampus (z = 3.45, P G 0.0001 regression; R = 0.41, P = 0.003 partial correlation) and bilaterally in the medial temporal lobe (right: z = 3.46, P G 0.0001 regression; R = 0.19, P = 0.17 partial correlation; left: z = 3.12, P = 0.001 regression; R = 0.33, P = 0.019 partial correlation).
Effect of hormone use on visual working memory
Significant activation differences were observed between treatment groups during the visual working memory task ( Table 3 , Fig. 1 ). The main effects of treatment occurred in the right inferior frontal lobe, anterior cingulate, left anterior insula, right parietal and left superior parietal cortices, left hippocampus and bilateral hippocampal gyrus, posterior cingulate, and the raphe. Compared with never-treated women, both HT groups had more regional activation (Table 4 ). ET women had more activation than did never-treated women bilaterally in the superior frontal lobe, left anterior and bilateral posterior insula, right superior and bilateral inferior frontal lobe, left hippocampus, and posterior cingulate. EPT women had more activation than did never-treated women in the right inferior and left superior frontal lobe, anterior cingulate, bilateral insula, right superior parietal lobe, bilateral hippocampus, left parahippocampal gyrus, and raphe. Nevertreated women did not have more activation in any region than did women in either of the HT groups. Table 5 presents a comparison of regional activation between the HT groups. Compared with ET women, the EPT group had greater activation in the left superior parietal cortex and bilateral parahippocampal gyrus. ET women had greater regional activity in the right superior frontal cortex, prefrontal cortex, and superior parietal cortex.
Because both current and past hormone users were included in the study, we compared activation patterns from current and past users of both HTs, controlling for age, education, duration of HT, and age at treatment initiation. Past users had more activation than did current users in a 544 mm 3 cluster within the right prefrontal cortex (z = 2.98), whereas current users did not have any regions significantly more activated than past users.
DISCUSSION
Historically, the cognitive benefits of postmenopausal HT have not been consistently demonstrated. The timing of treatment in relation to menopause is a probable source of differences in results between studies. Evidence suggests that All regions significant at P G 0.05, corrected for multiple comparisons (false detection rate method) or by a priori hypothesis at P G 0.001. treatment begun soon after menopause is most likely to impart a cognitive benefit. 9,13,15,41<44 Accordingly, continued studies focusing on cognitive outcomes in those women who began hormone use near the time of menopause are warranted. In this study, we addressed the cognitive effects of hormones in women who began long-term treatment close to the time of menopause and considered the type of hormone used. Our results indicate that early-initiation, long-term hormone use is associated with increased regional brain activation during a visual working memory task, with women in both HT groups exhibiting a more robust neural response than never-treated women did. In contrast to previous studies that have found a differential effect of progestins on cognitive performance measures, we did not identify a benefit to ET compared with EPT. 7, 16, 23 Our results support the hypothesis that long-term HT, when initiated close to menopause, maintains a positive effect on visual memory processes more than a decade later.
Prior neuroimaging studies have found differences in neural activity between postmenopausal hormone users and nonusers. The fMRI-BOLD method has measured increased regional activity in the frontal and parietal cortices, regions involved in working memory, in estrogen users versus nonusers during working memory tasks. 45 fMRI-BOLD has also demonstrated increased frontal activity during both verbal and spatial working memory tasks in perimenopausal and postmenopausal estrogen users versus nonusers. 44 Our group previously used fMRI-BOLD to compare brain activation patterns in women in their 50s after 4 weeks each of placebo or HT (5 Kg ethinyl estradiol and 1 mg norethindrone acetate), while the participants performed this same visual memory task. 26 The short-term hormone use was associated with All regions significant at P G 0.05, corrected for multiple comparisons (false detection rate method) or by a priori hypothesis at P G 0.001.
FIG. 1.
Neural activity during visual working memory is greater in women treated with EPT (left) or estrogen only (right) than in never-treated control subjects. During the working memory component of the delayed matching-to-sample task (4-to 1-s delay), regions that generated greater fMRI-BOLD signal in EPT-treated women than in never-treated women (left) include the posterior cingulate, inferior parietal cortex, insula, and putamen. Regions with greater fMRI-BOLD signal in estrogen-onlyYtreated women than in never-treated control subjects (right) include the posterior cingulate and inferior parietal cortex. Color scale depicts the T score of significant regions. fMRI-BOLD, blood oxygen levelYdependent functional magnetic resonance imaging; EPT, estrogen + progestin therapy. All regions significant at P G 0.05, corrected for multiple comparisons (false detection rate method) or by a priori hypothesis at P G 0.001. increased bilateral activation of the prefrontal cortex. The results of this previous study of acute estrogen effects in younger women are similar to those of the current study of chronic long-term hormone use, except the current study also identified greater activation in hormone users in brain regions associated with learning and memory, including the hippocampus, parahippocampal gyrus, and raphe.
In the present study, the increased fMRI-BOLD signal in hormone-treated women seems to reflect a benefit of hormone use. Increased brain activation can indicate less effective cognitive processing or inefficient compensatory mechanisms during early mild cognitive impairment and may predict future cognitive decline. 46, 47 Other studies, however, have found decreased neural activity indicative of cognitive decline, with increased activation in normal older adults. 48 In the current study, greater regional activity occurred in regions expected to be used during the visual working memory task, reflecting neural activation associated with processing visual information as required by the task. These results agree with increased neural activity observed in previous studies, including our own study of middle-aged women after 4 weeks of HT, a time frame unlikely to result in compensatory mechanisms associated with mild cognitive impairment but rather up-regulated synaptic activity reflecting greater estrogen availability. 26, 49 We also detected increased posterior cingulate activation in hormone users, a region where decreased activity can be predictive of Alzheimer disease. 50, 51 Finally, fMRI-BOLD signal in the right hippocampus, a region central to memory processing, positively correlated to task accuracy, implying a cognitive benefit to the increased activity measured during the visual memory task. Increased brain activation was correlated only to performance on the longer 4-second delay condition, and not the short 1-second delay condition, suggesting that the increased regional activation is specific to visual working memory processes.
Synthetic progestins, including the medroxyprogesterone acetate used by the women in this study, have potentially deleterious effects on cognitive performance. 9, 16, 52 However, we found that women in both HT groups had different activation patterns than those of never-treated women during the visual memory task, and these patterns did not differ greatly between the hormone-treated groups. Women in the EPT group had slightly more regional activation than did those in the ET group, most notably bilaterally in the parahippocampal gyrus, even after accounting for differences between the groups.
Many of the regions differentially activated between treatment groups are dense in estrogen receptors, progesterone receptors, or both. Estrogen receptor subtypes are present in limbic areas associated with emotional and cognitive processing and in regions connecting to cognitive association areas, including the amygdala, hippocampus, thalamus, and cortex. 53<56 Progesterone receptors are found in many of the same regions as estrogen receptors, partly because they are induced by estrogens. 57, 58 Women in both HT groups showed greater activation in many of these regions during the visual memory task compared with never-treated women.
Estrogen and progesterone receptors regionally decrease with age and are sensitive to exogenous hormones. 57, 59, 60 As both estrogens and progesterone provide neuroprotection and help prevent the degenerative effects of aging, 2,58,61,62 the increased activation in hormone-treated women may reflect preservation of cognitive association areas used during the visual task. This idea is supported by prior studies demonstrating increased parietal, occipital, cerebellar, and hippocampal volumes in postmenopausal women currently taking estrogen, 63, 64 although these findings are in contradiction to that of the WHIMS-MRI study showing increased hippocampal atrophy and size reduction in hormone users, albeit in older women. 65 The goal of this study was to examine the differences in visual working memory after chronic hormone use compared with no hormone use; thus, women who recently quit longterm HT were included along with current hormone users. Apart from a statistically significant difference in mean years of education, these two groups were demographically similar (although the smaller sample size used to compare current and past users may increase the likelihood of a type 2 error). Current and past hormone users had a similar pattern of neural activation during the visual memory task. After accounting for variations in age, education, duration of hormone use, and age at hormone initiation, current users did not have more activation than did past users in any part of the brain. Past users showed slightly more activation than did current users in only one small region within the prefrontal cortex. Although it is difficult to draw conclusions based on one differing region, these results may be consistent with others that have indicated a persisting cognitive benefit to past hormone users. 24, 64 Other than this region, the activation patterns between these two HT groups were sufficiently similar to justify including them in the same groups when comparing hormone ever users to never users.
Strengths of this study include the comparison of consistent hormone users to never users, with separate analyses of ET and EPT women, all on identical doses and formulations. This assessment of long-term use required a cross-sectional design because randomization to long-term hormone use was unfeasible. Our study examined the effects of chronic, rather than acute, hormone use and thus allowed inclusion of both current and past hormone users; women falling into these groups were demographically similar, had similar behavioral outcomes, and had only minor differences in brain activation during the visual task, suggesting a persisting chronic effect of long-term hormone use in these women. Demographic and hormone-use characteristics were kept as similar as possible between groups, and any factors that differed between groups were controlled for in the analyses. We did not include a comparison group of women who began hormone use well past menopause, but limiting our study to women who began hormone use early allowed us to include only women who used hormones long-term. A limitation of this design is the inability to separate the effects of early initiation from those of long-term use of hormones. Onset of menopause was self-defined, although whenever possible, we confirmed dates with healthcare records.
CONCLUSIONS
This study of early-initiation, long-term hormone use suggests that postmenopausal hormone use is beneficial to visual working memory. During our test of visual working memory, we observed more regional brain activation in hormone-treated women than in never-treated women, specifically in regions important to visual working memory. Controlling for differences in age and education, this increased regional activation was associated with better performance on the visual memory task. We found similarly positive effects in both ET-and EPT-treated women. Although long-term HT may not be beneficial in terms of chronic disease prevention, 66, 67 our results suggest that, if begun close to the onset of menopause, hormone use may benefit visual memory processes in postmenopausal women.
